The Multi-Kinase Inhibitor Ec-70124 Synergistically Increased the Anti-Tumor Activity of Doxorubicin in Sarcomas

International Journal of Cancer - United States
doi 10.1002/ijc.32081
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Combination Treatment With Doxorubicin and microRNA-21 Inhibitor Synergistically Augments Anticancer Activity Through Upregulation of Tumor Suppressing Genes

International Journal of Oncology
Cancer ResearchOncology
2015English

The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity

Marine Drugs
Drug Discovery
2015English

CX-4945: The Protein Kinase CK2 Inhibitor and Anti-Cancer Drug Shows Anti-Fungal Activity

Molecular and Cellular Biochemistry
MedicineClinical BiochemistryCell BiologyMolecular Biology
2017English

The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Exerts Immunomodulatory Activity Towards Tumor-Infiltrating Macrophages

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Inhibition of Flt3 and Pim Kinases by Ec-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

E7080, a Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Tumor Cell Migration and Invasion

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

In Vivo Anti-Tumor Activity of the PARP Inhibitor Niraparib in Homologous Recombination Deficient and Proficient Ovarian Carcinoma

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Increased Expression of the dsRNA-Activated Protein Kinase PKR in Breast Cancer Promotes Sensitivity to Doxorubicin

PLoS ONE
Multidisciplinary
2012English

Influence of the Proton Pump Inhibitor Lansoprazole on Distribution and Activity of Doxorubicin in Solid Tumors

Cancer Science
Cancer ResearchMedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy